Virax Biolabs Group Limited (VRAX)

$0.96 +0.04 (4.41%)
Market Cap 4.17M
Revenue (ttm) 10,000.00
Net Income (ttm) -6.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60,600.00%
Debt to Equity Ratio 0.01
Volume 372,000
Avg Vol 74,886
Day's Range N/A - N/A
Shares Out 4.34M
Stochastic %K 55%
Beta 1.65
Analysts Strong Sell
Price Target $3.00

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multi...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7788 7414
Address:
BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom
Jutulhonay
Jutulhonay Jul. 19 at 8:39 PM
$VRAX massive rally in works, starting my buying spree
0 · Reply
LewisDaKat
LewisDaKat Jul. 18 at 8:25 PM
News Article Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency https://marketwirenews.com/news-releases/virax-biolabs-announces-receipt-of-nasdaq-notificati-8822295321127664.html $VRAX
0 · Reply
WKUK
WKUK Jul. 18 at 4:55 PM
Somebody has been accumulating a solid number of shares over the last two weeks. Virax has been gearing up for a Q-submission to the FDA this quarter for their ViraxImmune assay. This is a major regulatory milestone that could pave the way for FDA clearance and commercial rollout and could also prove to be the catalyst that this stock needs. On top of that, they still have yet to announce their new CFO. The introduction of an experienced CFO with deep ties to the industry will help them when perusing private offerings or securing better financing. Don’t sleep on this one. Low float. High potential. Eyes on the prize. $VRAX
1 · Reply
Paulfrench
Paulfrench Jul. 18 at 6:33 AM
$VRAX I really wouldn't be surprised if we come back to retest the $0.78 level before making an attempt to cross the Kumo cloud...
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 17 at 8:24 PM
$DVLT coding $VISL will require $VRAX shortly
0 · Reply
WKUK
WKUK Jul. 17 at 2:27 PM
$VRAX Yes, let’s wake the fuck up
0 · Reply
Camaro12
Camaro12 Jul. 17 at 2:05 PM
$VRAX
0 · Reply
WKUK
WKUK Jul. 16 at 11:31 PM
$VRAX I've been accumulating a while now and it seems like we bottomed out, and I haven't been the only one buying. There is a meeting with the FDA coming up this quarter...
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 16 at 10:19 PM
$VRAX okok so i broguht the kids to u from ZBAI didnt tag them for now on this message busy man !
0 · Reply
PaulLaurent
PaulLaurent Jul. 15 at 1:12 PM
📢📊 Unusual Volume Stocks 📊📢 $XELB $EPIX $CALC $VRAX $MEIP
0 · Reply
Latest News on VRAX
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Jul 18, 2025, 4:15 PM EDT - 1 day ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 31, 2025, 2:57 PM EDT - 3 months ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 18, 2025, 7:30 AM EDT - 4 months ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 13, 2025, 7:30 AM EDT - 4 months ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 4 months ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Feb 25, 2025, 7:00 AM EST - 5 months ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 6 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 6 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 17, 2024, 7:30 AM EST - 7 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Dec 10, 2024, 7:30 AM EST - 7 months ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Oct 23, 2024, 7:30 AM EDT - 9 months ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 10 months ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 10 months ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Sep 9, 2024, 8:00 AM EDT - 11 months ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 29, 2024, 9:03 AM EDT - 11 months ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 2:18 PM EDT - 11 months ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 28, 2024, 7:30 AM EDT - 11 months ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 23, 2024, 4:09 PM EDT - 11 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 11 months ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 11 months ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 21, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Dec 14, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Jul 18, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

May 4, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Apr 19, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 10, 2023, 5:17 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 2 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Mar 7, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

Feb 7, 2023, 9:15 AM EST - 2 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Feb 7, 2023, 8:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Feb 6, 2023, 4:05 PM EST - 2 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Jan 4, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Dec 6, 2022, 7:30 AM EST - 2 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 15, 2022, 7:30 AM EST - 2 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 8, 2022, 4:30 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Nov 3, 2022, 7:30 AM EDT - 2 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Oct 26, 2022, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Sep 22, 2022, 8:07 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

COSM

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Sep 12, 2022, 7:00 AM EDT - 3 years ago

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Sep 6, 2022, 4:00 PM EDT - 3 years ago

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Aug 16, 2022, 7:31 AM EDT - 3 years ago

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Jul 26, 2022, 8:00 AM EDT - 3 years ago

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Investors May Want to Follow Progress of VC-Backed Medtechs

Jul 25, 2022, 6:19 PM EDT - 3 years ago

Investors May Want to Follow Progress of VC-Backed Medtechs

BHC BLCO MDT MHUA TNON

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

Jul 21, 2022, 10:33 AM EDT - 3 years ago

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

Jutulhonay
Jutulhonay Jul. 19 at 8:39 PM
$VRAX massive rally in works, starting my buying spree
0 · Reply
LewisDaKat
LewisDaKat Jul. 18 at 8:25 PM
News Article Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency https://marketwirenews.com/news-releases/virax-biolabs-announces-receipt-of-nasdaq-notificati-8822295321127664.html $VRAX
0 · Reply
WKUK
WKUK Jul. 18 at 4:55 PM
Somebody has been accumulating a solid number of shares over the last two weeks. Virax has been gearing up for a Q-submission to the FDA this quarter for their ViraxImmune assay. This is a major regulatory milestone that could pave the way for FDA clearance and commercial rollout and could also prove to be the catalyst that this stock needs. On top of that, they still have yet to announce their new CFO. The introduction of an experienced CFO with deep ties to the industry will help them when perusing private offerings or securing better financing. Don’t sleep on this one. Low float. High potential. Eyes on the prize. $VRAX
1 · Reply
Paulfrench
Paulfrench Jul. 18 at 6:33 AM
$VRAX I really wouldn't be surprised if we come back to retest the $0.78 level before making an attempt to cross the Kumo cloud...
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 17 at 8:24 PM
$DVLT coding $VISL will require $VRAX shortly
0 · Reply
WKUK
WKUK Jul. 17 at 2:27 PM
$VRAX Yes, let’s wake the fuck up
0 · Reply
Camaro12
Camaro12 Jul. 17 at 2:05 PM
$VRAX
0 · Reply
WKUK
WKUK Jul. 16 at 11:31 PM
$VRAX I've been accumulating a while now and it seems like we bottomed out, and I haven't been the only one buying. There is a meeting with the FDA coming up this quarter...
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 16 at 10:19 PM
$VRAX okok so i broguht the kids to u from ZBAI didnt tag them for now on this message busy man !
0 · Reply
PaulLaurent
PaulLaurent Jul. 15 at 1:12 PM
📢📊 Unusual Volume Stocks 📊📢 $XELB $EPIX $CALC $VRAX $MEIP
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 14 at 10:39 PM
$MTC $VRAX $WTO changing timing 4 all 3 of u 1 by 1 partial pivots coming going into tomo and end of week
1 · Reply
Love_To_Learn
Love_To_Learn Jul. 14 at 9:43 PM
$VRAX been accumulating
2 · Reply
Ashtooon
Ashtooon Jul. 14 at 2:20 PM
$VRAX Tomorrow will be huge.
2 · Reply
PaulLaurent
PaulLaurent Jul. 13 at 4:26 PM
📢📊 Unusual Volume Stocks 📊📢 $BQ $IBG $ATHE $CNTB $VRAX
0 · Reply
cghowells
cghowells Jul. 9 at 2:45 PM
$VRAX LFG ✅✅🚀🚀💷💷
0 · Reply
cghowells
cghowells Jul. 8 at 2:59 PM
$VRAX Just bought more. With the new covid strains, hoping this will rocket again ✅✅✅🚀🚀🚀
0 · Reply
StockOperator69
StockOperator69 Jul. 7 at 12:46 AM
$VRAX
0 · Reply
Xenocyde
Xenocyde Jun. 30 at 12:00 PM
$VRAX huh what happened to all the ucla posts… I guess he finally weeee’d and durrrr’d himself into oblivion. 🤣
1 · Reply
ucla44life
ucla44life Jun. 27 at 3:18 PM
$VRAX MM's scamming, don't get taken...collapse inbound :-)
0 · Reply
CrustyNuggs
CrustyNuggs Jun. 26 at 8:03 PM
$VRAX the idiot from reddits back haha we’ve hit the bottom go cry somewhere else
1 · Reply
ucla44life
ucla44life Jun. 26 at 5:00 PM
$VRAX single digit shares being traded is cool and very bullish right? SCAM GOING TO 60'S SOON...what a piece of shit run by a con artist, do real research and don't listen to desperate bag holders and these once-a-week newbies with bogus realities and even crazier price predictions. TRASH!
0 · Reply
PenkeTrading
PenkeTrading Jun. 26 at 3:43 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Virax Biolabs Group Limited Ordinary Shares. Is that bullish or bearish? $VRAX #RsiOversold #NASDAQ
0 · Reply